What medications can stop heavy uterine bleeding?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Medications for Heavy Uterine Bleeding

First-line medical treatments for heavy uterine bleeding include NSAIDs for 5-7 days during bleeding episodes, tranexamic acid for 4-5 days starting on the first day of bleeding, and hormonal contraceptives such as combined oral contraceptives or levonorgestrel IUD. 1

First-Line Treatment Options

NSAIDs

  • NSAIDs (naproxen, mefenamic acid, ibuprofen) reduce menstrual blood loss by 26-60% when used for 5-7 days during bleeding episodes 1
  • Particularly effective for copper IUD users with heavy bleeding
  • Mechanism: Reduces prostaglandin production that contributes to excessive bleeding

Tranexamic Acid

  • Reduces menstrual blood loss by approximately 50% 1
  • Used for 4-5 days starting from the first day of menstrual cycle
  • Contraindicated in women with active thromboembolic disease or history/risk of thrombosis
  • Non-hormonal option for women who cannot use hormonal treatments

Hormonal Options

  • Combined Oral Contraceptives (COCs)

    • Effective for short-term treatment (10-20 days) of heavy bleeding 1
    • Can be used for long-term management
    • Typical failure rate of 5-9%
    • If started more than 5 days after menstrual bleeding began, use backup contraception for 7 days
  • Levonorgestrel Intrauterine Device (LNG-IUD)

    • Highly effective for heavy menstrual bleeding 2, 1
    • Typical failure rate of 0.1-0.2%
    • Provides long-term relief and contraception
    • First-line option for contraception and dysmenorrhea management
  • Progestin-Only Pills

    • Can be started anytime, but if started more than 5 days after menses, use backup method for 2 days 1
    • Typical failure rate of 5-9%

Second-Line Treatment Options

GnRH Agonists and Antagonists

  • Parenteral GnRH agonists (leuprolide acetate) and oral GnRH antagonists (elagolix, linzagolix, relugolix) 2
  • Effective at reducing bleeding symptoms and tumor volume
  • Often used for short courses to decrease fibroid size before surgery
  • Side effects: hypoestrogenic effects (headaches, hot flushes, hypertension, bone mineral density loss)
  • Combination treatment with low doses of estrogen and progestin can mitigate these symptoms

Intravenous Estrogen

  • For acute, severe bleeding episodes 3, 4
  • Rapidly controls bleeding
  • Short-term use only
  • Contraindicated in women with history of stroke, heart attack, blood clots, or liver problems

Management Algorithm for Heavy Uterine Bleeding

  1. For acute, severe bleeding causing hypovolemia:

    • Consider intravenous estrogen therapy 4
    • Curettage may be indicated for patients with hypovolemia 4
  2. For chronic heavy bleeding:

    • Start with NSAIDs for 5-7 days during bleeding episodes 2, 1
    • If ineffective, add tranexamic acid for 4-5 days starting on day 1 of bleeding 1, 5
    • For women needing contraception, consider hormonal options:
      • LNG-IUD (most effective, reduces bleeding by >90% after 12 months) 1, 5
      • Combined oral contraceptives (if no contraindications) 1
      • Progestin-only pills 1
  3. For bleeding associated with uterine fibroids:

    • NSAIDs and tranexamic acid for short-term management 2
    • GnRH agonists/antagonists to reduce fibroid size and bleeding 2
    • Consider LNG-IUD if fibroids don't distort the uterine cavity 2, 1

Special Considerations

Bleeding with Hormonal Contraceptives

  • For unscheduled spotting or light bleeding with LNG-IUD or implant users:
    • NSAIDs for 5-7 days 2
    • Hormonal treatment with COCs if medically eligible 2

Contraindications

  • Combined hormonal methods are contraindicated in women with:
    • History of stroke or heart attack 3
    • Current or past blood clots 3
    • Current or past liver problems 3
    • Diagnosed bleeding disorders 3

Monitoring

  • If bleeding persists despite treatment, evaluate for underlying conditions 2, 1
  • Consider endometrial sampling in perimenopausal women due to higher risk of endometrial hyperplasia/cancer 1

Common Pitfalls to Avoid

  1. Failing to rule out underlying pathology: Always consider organic causes of bleeding before attributing to hormonal imbalance 5

  2. Inadequate treatment duration: NSAIDs and tranexamic acid must be used for the full recommended duration (5-7 days for NSAIDs, 4-5 days for tranexamic acid) to be effective 1

  3. Ignoring bleeding disorders: Consider von Willebrand disease and other coagulation disorders in women with persistent heavy bleeding 4, 6

  4. Thrombosis risk with treatment: Be cautious with tranexamic acid and hormonal treatments in women with risk factors for thrombosis 6

  5. Expecting immediate results: Counsel patients that hormonal methods may cause irregular bleeding during the first 3 months of use before improvement occurs 1

References

Guideline

Management of Irregular Menstrual Bleeding

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Management of abnormal uterine bleeding.

American journal of obstetrics and gynecology, 1996

Research

Clinical practice guidelines on menorrhagia: management of abnormal uterine bleeding before menopause.

European journal of obstetrics, gynecology, and reproductive biology, 2010

Research

Bleeding vs Thrombosis: Treatment Strategy for Women Having Large Uterine Fibroids and DVT.

Current reviews in clinical and experimental pharmacology, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.